Risk assessment for Japanese encephalitis vaccination
- PMID: 29244615
- PMCID: PMC5791557
- DOI: 10.1080/21645515.2017.1380756
Risk assessment for Japanese encephalitis vaccination
Abstract
Japanese encephalitis (JE) is the most commonly diagnosed viral encephalitis in Asia. JE is caused by a virus called JE virus (JEV), a member of the genus Flavivirus, family Flaviviridae, and is transmitted by Culex mosquitoes. Neutralising antibody to JEV protects against JE, and can be induced by vaccination. JE is a potential threat to travellers to endemic areas, which are most of South and Southeast Asia and some Pacific Islands. The risk of JE can be expected to increase with increasing mosquito exposure and time spent in regions and seasons of active transmission. JE is very rare in travellers, but mortality is high, around 1 in 3, and there is a high rate of lasting neurological damage. JE can therefore be a profoundly life changing event for a traveller. Travellers and their healthcare providers need to balance the low risk of disease against the very high severity of disease if it does occur. In order to make an informed decision, the severity of JE disease should be carefully explained to travellers to Asia.
Keywords: Japanese encephalitis; risk assessment; travellers; vaccination.
Figures
Similar articles
-
'More than devastating'-patient experiences and neurological sequelae of Japanese encephalitis§.J Travel Med. 2019 Oct 14;26(7):taz064. doi: 10.1093/jtm/taz064. J Travel Med. 2019. PMID: 31504712 Free PMC article.
-
Recent and historical trends in the epidemiology of Japanese encephalitis and its implication for risk assessment in travellers.J Travel Med. 2018 May 1;25(suppl_1):S3-S9. doi: 10.1093/jtm/tay006. J Travel Med. 2018. PMID: 29718434 Review.
-
Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).Expert Opin Biol Ther. 2012 Sep;12(9):1251-63. doi: 10.1517/14712598.2012.704908. Epub 2012 Jul 9. Expert Opin Biol Ther. 2012. PMID: 22775524 Review.
-
Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 Mar 12;59(RR-1):1-27. MMWR Recomm Rep. 2010. PMID: 20224546
-
Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.PLoS Negl Trop Dis. 2017 Jan 30;11(1):e0005263. doi: 10.1371/journal.pntd.0005263. eCollection 2017 Jan. PLoS Negl Trop Dis. 2017. PMID: 28135273 Free PMC article. Clinical Trial.
Cited by
-
Seroconversion, genotyping, and potential mosquito vector identification of Japanese encephalitis virus in pig sentinel settings in Bali, Indonesia.Vet World. 2024 Jan;17(1):89-98. doi: 10.14202/vetworld.2024.89-98. Epub 2024 Jan 8. Vet World. 2024. PMID: 38406355 Free PMC article.
-
EGFR Activation Impairs Antiviral Activity of Interferon Signaling in Brain Microvascular Endothelial Cells During Japanese Encephalitis Virus Infection.Front Microbiol. 2022 Jun 30;13:894356. doi: 10.3389/fmicb.2022.894356. eCollection 2022. Front Microbiol. 2022. PMID: 35847084 Free PMC article.
-
Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening.Antiviral Res. 2020 Oct;182:104884. doi: 10.1016/j.antiviral.2020.104884. Epub 2020 Aug 1. Antiviral Res. 2020. PMID: 32750466 Free PMC article.
-
'More than devastating'-patient experiences and neurological sequelae of Japanese encephalitis§.J Travel Med. 2019 Oct 14;26(7):taz064. doi: 10.1093/jtm/taz064. J Travel Med. 2019. PMID: 31504712 Free PMC article.
-
Review of Emerging Japanese Encephalitis Virus: New Aspects and Concepts about Entry into the Brain and Inter-Cellular Spreading.Pathogens. 2019 Jul 26;8(3):111. doi: 10.3390/pathogens8030111. Pathogens. 2019. PMID: 31357540 Free PMC article. Review.
References
-
- Watt G, Jongsakul K. Acute undifferentiated fever caused by infection with Japanese encephalitis virus. Am J Trop Med Hyg. 2003;68:704-6. PMID:12887030. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
